Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

RBG Not On Bench For Supreme Court’s First Day Of Arguments

WASHINGTON (Reuters) – U.S. Supreme Court Justice Ruth Bader Ginsburg will be working from home and will not participate from the bench during the two scheduled oral arguments on Monday after undergoing surgery for lung cancer last month, a court spokeswoman said.

Ginsburg, 85, will instead use the case briefs and transcripts to participate in the cases, court spokeswoman Kathy Arberg said. The liberal justice underwent surgery at Memorial Sloan Kettering Cancer Center in New York to remove two cancerous nodules in her left lung and was released from the hospital on Dec. 25.

Monday’s arguments in two cases were the first on the court’s schedule since Ginsburg underwent the procedure called a called a pulmonary lobectomy on Dec. 21. After the surgery, the court said there was no evidence of remaining disease.

It was the first time Ginsburg, one of the court’s nine justices, has missed oral arguments as a result of her various health scares, including two previous cancer diagnoses.

As the oldest justice, Ginsburg is closely watched for any signs of deteriorating health. Ginsburg, appointed by Democratic President Bill Clinton in 1993, also is the senior liberal member of the court, which has a 5-4 conservative majority.

Ginsburg broke three ribs in a fall in November. The nodules were found as part of the tests the justice underwent after the earlier fall, according to the court.

Ginsburg was treated in 1999 for colon cancer and again in 2009 for pancreatic cancer but did not miss any argument sessions either time. In 2014, doctors placed a stent in her right coronary artery to improve blood flow after she reported discomfort following routine exercise. She was released from a hospital the next day.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.